- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
NanoSphere President David Sutton Interviewed on #CanadaPotTalks
NanoSphere Health Sciences (CSE:NSHS) President David Sutton was interviewed on #CanadaPotTalks, a Roundhouse Radio 98.3 radio show.
NanoSphere Health Sciences (CSE:NSHS) President David Sutton was interviewed on #CanadaPotTalks, a Roundhouse Radio 98.3 radio show. The show is broadcast in collaboration with Niche Canada, a non-profit organization that supports the safe transition to cannabis legalization, and Steven Feldman, the owner of the social media account @CanadaPotStocks.
During the interview, Sutton discussed how NanoSphere entered the Canadian space by using the technology developed by Dr. Richard Kaufman to develop a nano-nutraceutical line of products. In designing these products, the company discovered the viability for this technology to be implemented in other spaces, including with cannabis, where the approach would be able to increase the drug’s bioavailability.
The company president also discussed the company’s primary product—the NanoSphere Delivery System—and described how it adapts the cannabinoid particles to make them easier to absorb and more effective. He also addressed the company’s other products, including a topical salve, which can assist in pain relief, anxiety reduction and sleep control. These products are becoming more available to patients as the company works to educate medical professionals of their benefits.
To listen to the full interview, click here. Interview begins near the 30 minute mark.
Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an investor presentation
Source: cirh2.streamon.fm
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.